Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(19 sites)
United States
Stanford University Medical Center, Stanford, California Barbara Davis Center / University of Colorado Denver, Aurora, Colorado AdventHealth, Orlando, Florida Northwestern University Feinberg School of Medicine, Chicago, Illinois Joslin Diabetes Center, Boston, Massachusetts Washington University, St Louis, Missouri SUNY Upstate Medical University, Syracuse, New York Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx, New York Cleveland Clinic Foundation, Cleveland, Ohio Oregon Health and Science University, Portland, Oregon University of Texas Southwestern, Dallas, Texas University of Washington, Seattle, Washington Providence Sacred Heart Medical Center, Spokane, Washington Canada
Unversity of Calgary, Calgary, Alberta Alberta Diabetes Institute, Edmonton, Alberta St. Paul's Hospital, Vancouver, British Columbia LMC Diabetes and Endocrinology, Toronto, Ontario Toronto General Hospital, Toronto, Ontario Institut de Recherches Cliniques de Montréal, Montreal, Quebec